
Oncology NEWS International
- Oncology NEWS International Vol 11 No 4
- Volume 11
- Issue 4
IOM Reverses Finding of Childhood AML Link to Parent’s Vietnam Service
WASHINGTON-After further review, a committee of the Institute of Medicine (IOM) has rescinded its earlier finding of a suggestive link between the exposure of veterans to herbicides used during the Vietnam War and an increased risk of their offspring developing acute myelogenous leukemia (AML). The committee’s reanalysis followed the finding that one study that it had relied on was in error.
WASHINGTONAfter further review, a committee of the Institute of Medicine (IOM) has rescinded its earlier finding of a suggestive link between the exposure of veterans to herbicides used during the Vietnam War and an increased risk of their offspring developing acute myelogenous leukemia (AML). The committee’s reanalysis followed the finding that one study that it had relied on was in error.
The panel based its prior conclusion, contained in a report released in April 2001, in part on an Australian study that found a statistical link between the service of Australian veterans in Vietnam and the incidence of AML among their children. That study, however, was later found to contain a miscalculation that resulted in the conclusion that the children had a significantly increased risk of the disease. The actual incidence was within the range that would be expected in the general population.
The IOM panel also included two new studies, one from Germany and the other from Norway, in its newest review of data. The two studies examined the incidence of AML in the children of parents who had experienced occupational exposure to pesticides and found no significant difference, compared with children of unexposed parents.
Articles in this issue
over 23 years ago
Virtual Shared Specimen Resource ‘Essential’over 23 years ago
DHA Conjugate Increases Paclitaxel Uptake by Tumor Cellsover 23 years ago
Letrozole Superior to Tamoxifen in Metastatic Breast Cancerover 23 years ago
S-8184 Paclitaxel Emulsion Promising in Phase I Studyover 23 years ago
HIV+ Veterans Have Higher Rates of Unusual Cancersover 23 years ago
Online Breast Cancer Support Groups Beneficialover 23 years ago
Survival Benefit With Capecitabine/Docetaxelover 23 years ago
FDA Approves Zometa for Cancer-Related Bone ComplicationsNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.


















































































